Cipla and hetero seek clinical trial waiver for Remdesivir

While all new drugs must undergo trials before getting marketing approval in India, the regulator can grant exemptions in public interest and in cases of national emergency, extreme urgency and epidemics.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XqzKTn
via IFTTT